Enhanced Iontophoretic Delivery of Risedronate Sodium Across Hairless Mice Skin

[1]  P. Stiff,et al.  Management of the adverse effects associated with intravenous bisphosphonates. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  K. Zhao,et al.  Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector , 2006 .

[3]  E. Woolf,et al.  Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  H. Gwak,et al.  Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. , 2002, International journal of pharmaceutics.

[5]  B. Sage,et al.  Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  T. Koizumi,et al.  Effect of pH on skin permeation enhancement of acidic drugs by l-menthol-ethanol system. , 2001, International journal of pharmaceutics.

[7]  C. Ramachandran,et al.  Transdermal delivery of drugs for the treatment of bone diseases. , 2000, Advanced drug delivery reviews.

[8]  Y. Kalia,et al.  Iontophoresis: electrorepulsion and electroosmosis. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[9]  P. Beronius,et al.  On iontophoretic delivery enhancement: Ionization and mobility of lidocaine hydrochloride in propylene glycol , 1998 .

[10]  G. Rodan,et al.  Bisphosphonates: mechanisms of action , 1998, Endocrine reviews.

[11]  R. Francis.  Oral bisphosphonates in the treatment of osteoporosis: a review , 1995 .

[12]  K. Sharma,et al.  Transdermal delivery of buprenorphine through cadaver skin. , 1994, Journal of pharmaceutical sciences.

[13]  Michael J. Pikal,et al.  The role of electroosmotic flow in transdermal iontophoresis , 1992 .

[14]  M. Geraci.  Drug Class Review Oral Bisphosphonates in the Treatment of Osteoporosis , 2003 .

[15]  K. Sugibayashi,et al.  Mechanism of skin penetration-enhancing effect by laurocapram. , 1992, Journal of pharmaceutical sciences.

[16]  M. Pikal,et al.  The role of electroosmotic flow in transdermal iontophoresis. , 1992, Advanced drug delivery reviews.